4th Annual FEMA Regulations & Foreign Investments Masterclass (Gurgaon)

In the light of economic reforms and the liberalised business scenario in the country, the Foreign Exchange Management Act (FEMA) was introduced in India in 1999 which emerged as an investor friendly legislation. This act relaxed foreign exchange restrictions resulting in significant flow of investments into India over the years making it one of the most lucrative FDI destinations in the world. On the other hand Indian businesses have also been very aggressive in making investments overseas. Such rising inbound and outbound investments make it crucial to understand those regulations that govern such capital inflows and outflows. All transactions involving foreign exchange fall under preview of Foreign Exchange Management Act (FEMA) read with FDI policy.

On 7 November 2017, the Reserve Bank of India (RBI) issued Foreign Exchange Management (Transfer and Issue of Security by a Person Resident Outside India) Regulations, 2017 (New FEMA 20) to replace the Foreign Exchange Management (Transfer and Issue of Security by a Person Resident Outside India) Regulations, 2000 (Old FEMA 20) and the Foreign Exchange Management (Investments in Firms or Proprietary concern in India) Regulations, 2000 (FEMA 24).  New FEMA 20 consolidates Old FEMA 20 and FEMA 24. The New FEMA 20 eliminates several redundancies and clarifies a plethora of interpretational issues that plagued old regime.

Also in June 2018, the Reserve Bank of India (RBI) has issued two important circulars with the aim of simplifying reporting under the Foreign Exchange and Management Act, 1999 (FEMA).

CorpKonnect’s full day workshop on FEMA Regulations and Foreign Investments will identify and throw light on various issues related to FEMA compliances and investments into and from India.

Benefits of attending:

  • Know the regulations of Foreign Exchange Transactions
  • Understand the critical aspects related to Inbound and Outbound investments
  • Gain insights on how to set up business in India
  • Learn the important aspects of external commercial borrowings
  • Know the latest changes in the New consolidated FDI Policy

Who should attend:

  • CFOs
  • Company Secretaries
  • Finance and Accounts Executives
  • Corporate/General/In-house Counsel
  • Commercial and Investment Bankers
  • Foreign Exchange Dealers
  • Chartered Accountants
  • HNIs
  • Investment Trusts

Session 1: FDI Policy - Latest Changes and Emerging Issues

  • Policy Framework
  • Overall view of FDI Policy 2018 - Latest Changes

Master Directions on Foreign Investments and Reporting

  • FDI vs FPI Investments
  • Pricing ambiguity regarding listed securities
  • Downstream Investments

The new Reporting requirements

Transfer of Shares: 
FEMA Notification No. 20(R)/ 2017-RB – Latest Changes

  • Intricate Issues in Transfer of Share
        - Resident to Non-Resident
       - Non-Resident to Resident
      - Non-Resident to Non-Resident
  • Deferment of payment consideration

Reporting Compliances


Session 2: ODI regulations - Investment Routes

  • Eligible Investors and General Prohibition
  • Direct Investments Abroad by
       - Corporates & Registered Partnership Firms
       - Individuals
  • ODI by Trust and Societies
  • Funding Mechanism
  • Valuation and Compliances
  • Restructuring of Investments
  • Exit

Liberalized Remittance Scheme – Latest Developments


Session 3: The New FEMA Cross Border Merger Regulations

  • Background
  • Key Provisions of the new regulations
  • Provisions related to inbound merger
  • Provisions related to outbound merger
  • Hits & Misses of the new regulations
  • Challenges merging entities may face under the new framework

Session 4: 
External Commercial Borrowings (ECB) Policy

ECB Rationalisation and Liberalisation

  • Rationalisation of all-in-cost for ECB under all tracks and Rupee denominated bonds
  • Revisiting ECB Liability to Equity Ratio provisions
  • Expansion of Eligible Borrowers’ list for the purpose of ECB
  • Rationalisation of end-use provisions for ECBs

Recent FPI Related Changes:

  • Latest change in the legal framework of FPI in debt securities
  • FPI Investments – Strict Compliance for Listed entities
Arpita Garg
J. Sagar Associates

Arpita practices in the areas of Banking & Finance and General Corporate Commercial.

She has advised domestic and international clients in Banking & Finance related transactions including Syndicated Lending (secured & unsecured), domestic & External Commercial Borrowings, Project Financing, Acquisition Financing and Debt Restructuring. She has also advised clients on exchange control laws, security creation and general Corporate Commercial laws.

Before joining JSA, she was working with ICICI Bank Limited, Mumbai in their Corporate Legal Department. During her time spent at ICICI Bank, Arpita has worked on various corporate financing and project lending to multinational and domestic companies.

Prakriti Jaiswal
Principal Associate
J. Sagar Associates

Prakriti specialises in Mergers & cross border investments & acquisitions. Her experience includes rendering advisory and structuring services on a variety of transactions including acquisitions of shares & business, Private Equity investments, Joint Ventures and corporate advisory.

Prakriti has represented & advised various Indian and overseas acquirers, Indian investee companies and promoters, investment funds in a variety of industry sectors including Pharmaceutical, Logistics, Power, Manufacturing Industry, Infrastructure, IT, Financial Services, and the Hospitality sector.

Before joining JSA, she was associated with Desai & Diwanji, one of India’s premier and oldest law firms.

Shinoj Koshy
Luthra & Luthra Law Offices

Shinoj Koshy is a partner with Luthra & Luthra Law Offices, New Delhi.

Mr. Koshy is a dual-qualified lawyer with extensive experience in domestic and cross-border M&A transactions. His practice focuses on corporate transactions, particularly M&A (in telecom, logistics and outsourcing), joint ventures, corporate finance (equity and debt listings through primary and secondary offerings) and commercial dispute resolution (shareholder disputes and post-closing pricing disputes in M&A).

He has advised several corporates and PE funds on foreign investment strategies for emerging markets like India and countries in Middle East & North Africa. He is also associated with industry associations like FICCI and Invest India, advising them on ways to promote FDI in key sectors like infrastructure, manufacturing and retail. Additionally he is also a member of the India-Jersey Advisory Group advising the States of Jersey government on its interactions with the Government of India.

Abhijeet Das
Principal Associate
Vaish Associates Advocates

Abhijeet Das is a Senior Associate with Vaish Associates Advocates with eight years of experience, inter alia assisting/representing a broad spectrum of domestic and foreign clients on Indian corporate laws including vis-à-vis private equity transactions. His practice also includes assistance concerning securing and protection of intellectual property rights and providing transactional guidance on a diverse range of intellectual property assignment and licensing arrangements.

Over the years he has carved a nich in the Life Sciences and Healthcare sphere, which includes the legal and regulatory issues pertaining to clinical trials; advising various pharmaceutical companies, clinical research organizations, healthcare institutions and notable ethics committees on the niceties of the sector.

Some of his publications in the field are illustrated below:

  • Co-authored an article published in ‘Express Healthcare’ (a Financial Express publication) Vol. 11, No. 6, June 2017 India’s Foremost Healthcare Magazine (Indian Express), titled, “The Medical Devices Rules, 2017 – Industry Implications and Action Required”;
  • Authored an article published in ‘Express Pharma’ (a Financial Express publication), titled, “DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?” dated March 21, 2016;
  • Co-authored an article published in ‘Express Pharma’ (a Financial Express publication) Vol. 10, No. 5, 01-15, January 2015, titled, “Clinical research in 2015: The ghost of Christmas past, present and yet to come”; and
  • Co-authored an article published in ‘The Hindu – Business Line’, titled, “Clinical trial research is no crime”, dated December 1, 2014.


Hotel Radisson
Adjacent to Plot No 406, NH 8, Udyog Vihar Phase III, Gurugram
0124 - 4942555
Get Direction

Registration FeesINR 8,500 + 18% GST per delegate

Group Discount: 10% Discount on a Group of 2 or more Delegates

Note: The fees would include Course Material and Lunch & Refreshments at the Hotel

Payment Details:

Cheque/DD: Cheque/DD to be drawn in favour of E Watch Media and Learning Solutions LLP

Please courier the cheque to: B-106, Sector 65, Noida 201301, UP, India

Bank Details for NEFT/RTGS/Cash Deposit   

Bank Name


Beneficiary Name

E Watch Media and Learning Solutions LLP

Current Account No




Brach Name

Sector 62 Noida

For Credit Card Payment: CLICK HERE

For any other information, please contact
Biplab SenGupta
Mob: +91- 8130826342

Email: training@corpkonnect.com  
Website: www.corpkonnect.com